The immunohistochemistry (IHC) and in-situ hybridization (ISH) automated platform is a product used in the histology laboratory to help the pathologists and clinicians determine the disease status…
Ended Awarded Last action
- Contract number
- W81K0225FA137
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $342,049
Award facts
- Contract value 100% obligated
- $342,049.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Joint Base Lewis-McChord, WA, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $44,120 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $297,929 | |
| Original award | $0 |
About this award
The Defense Health Agency issued a delivery order to Roche Diagnostics Corporation on October 1, 2025, for an immunohistochemistry and in-situ hybridization automated platform supporting histology laboratory pathology services at Joint Base Lewis-McChord, Washington. The order carries a ceiling value of $342,049.17 under firm fixed-price terms, with performance concluding on September 30, 2026.
The immunohistochemistry and in-situ hybridization platform is used in histology laboratories to assist pathologists and clinicians in determining disease status of biopsy tissues for proper diagnosis. No set-aside was applied to this delivery order.
Description
The immunohistochemistry (IHC) and in-situ hybridization (ISH) automated platform is a product used in the histology laboratory to help the pathologists and clinicians determine the disease status of biopsy tissues for proper diagnosis.
Quick answers
Who was awarded contract W81K0225FA137?
W81K0225FA137 was awarded to Roche Diagnostics Corporation by Defense Health Agency (Department of Defense) on October 1, 2025.
How much is contract W81K0225FA137 worth?
The government has obligated $342,049 on W81K0225FA137.
Is contract W81K0225FA137 an order under another contract?
Yes. W81K0225FA137 is a delivery order under W81K0225DA013, an indefinite delivery contract.
Was contract W81K0225FA137 competed?
The extent of competition for W81K0225FA137 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award